Compare2 funds · 1 pair
Picked · 2YTD
Close to theseFee · YTD
Best of the twoNov 6
  • Lowest cost$ a year on $10kXLV 0.08%
  • Most incometrailing 12-month yieldBBC 1.52%
  • Best 5 yearsper yearXLV +8.4%
  • Smallest drop · 1Yworst fall in the past yearXLV −10.5%
Measures won2–4XLV wins · of 6 · 5Y
$10,000 · 5Y$14,979XLV · BBC $9,995
Lowest cost0.08%XLV · $8 on $10k
Most income1.52%BBC · $152 on $10k
Smallest drop−10.5%XLV · worst fall in 1Y
Held in common0.0%BBC and XLV

BBC vs XLV

5Y
BBC
XLV
Virtus Biotech Clinical Trials ETF · $34MState Street Health Care Select Sector SPDR ETF · $50.9B
+34.8%3 years · per year$24,485 · $15,566+15.9%
−0.0%5 years · per year$9,995 · $14,979+8.4%
0.65%Expense ratio$65 · $8 on $10k · lower wins0.08%
1.52%12-mo yield$152 · $138 on $10k1.38%
−30.2%Worst dropSmaller wins−10.5%
38.6%VolatilityLower wins16.8%
2–4XLV wins
$10,000 · 5 yearsOne scale
$10k startXLV $15.0kBBC $10.0kOct 2021Nov 2026
Shared top holdingsBBC · XLV

They share no top holdings, or holdings aren’t on file […]

Held in common0.0%
End-of-day Nov 6, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two
@TheETFTracker·theetftracker.com

Both

5Y2 funds
#Trend
1BXLVState Street Health Care Select Sector SPDR ETFReadDesk0.08%1.38%−0.1%+20.9%+29.0%+15.9%+8.4%−10.5%$50.9B
2ABBCVirtus Biotech Clinical Trials ETFReadDesk0.65%1.52%+5.6%+11.6%+46.1%+34.8%0.0%−30.2%$34M
End-of-day Nov 6, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
@TheETFTracker·theetftracker.com

Cards for this view

BBC vs XLV

5Y
Virtus Biotech Clinical Trials
$9,995
Health Care Select Sector SPDR
$14,979
$5k$10kNov 2021Nov 2026$9,995$14,979$5k$10kNov 2021Nov 2026$9,995$14,979
MeasureBBCXLV
Fee0.65%0.08%
Cost on $10k a year$65$8
Yield1.52%1.38%
5 years, per year−0.0%+8.4%
3 years, per year+34.8%+15.9%
Worst drop · 1Y−30.2%−10.5%
Volatility · 1Y38.6%16.8%
4–2measures won
XLV first
0.0%
holdings shared
Nov 6, 2026 · $10,000 five years ago, dividends reinvested
@TheETFTracker·theetftracker.com

SCHD vs VIG

YTD
SchwabSCHD
+31.4%
VIGVanguard
+12.1%
Jan 1Nov 6+31.4%+12.1%
+31.4%Year to date+12.1%
3.0%Yield1.5%
$120BAssets$109B
2–0SCHD wins
End-of-day Nov 6, 2026
@TheETFTracker·theetftracker.com

JEPQ vs JEPI

YTD
J.P. MorganJEPQ
+3.2%
JEPIJ.P. Morgan
+5.3%
Jan 1Nov 6+3.2%+5.3%
+3.2%Year to date+5.3%
12.8%Yield8.1%
$42.6BAssets$46.8B
1–1level
End-of-day Nov 6, 2026
@TheETFTracker·theetftracker.com

SPYM vs SPY

YTD
SPDRSPYM
+8.8%
SPYSPDR
+8.7%
Jan 1Nov 6+8.8%+8.7%
+8.8%Year to date+8.7%
1.1%Yield1.0%
$182BAssets$819B
2–0SPYM wins
End-of-day Nov 6, 2026
@TheETFTracker·theetftracker.com

Overlap: BBC, XLV

Today
0.0%most shared, BBC and XLV
BBCXLV
BBC—0.0%
XLV0.0%—
End-of-day Nov 6, 2026 · share held in common · outlined: the pair in versus
@TheETFTracker·theetftracker.com

Income After Fees on $10,000

1Y
$130most kept, XLV
XLV$138 − $8 = $130
BBC$152 − $65 = $87
KeptFee
End-of-day Nov 6, 2026 · yield in dollars minus the fee
@TheETFTracker·theetftracker.com